Fasting Time Effects in Time-Restricted Eating (FaTE-TRE)

NCT ID: NCT04503005

Last Updated: 2021-04-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-08

Study Completion Date

2022-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Over the past century, lifestyles and eating habits have rapidly changed, helping to increase the onset of conditions such as obesity, metabolic syndrome and the risk of cardiovascular and metabolic diseases such as diabetes.

Recently, dietary regimens such as calorie restriction and intermittent fasting have been promoted as new strategies for reducing obesity and related co-morbidities. These strategies have proven effective in reducing body fat, improving blood pressure, lipid profile and insulin resistance in overweight individuals. However, due to the rigidity of these food protocols, the adherence of subjects to the diet is often limited or maintained only for short periods.

Time-Restricted Eating (TRE) is a less extreme form of intermittent fasting, in which the subject's daily calorie intake is consumed only in a certain period of time during the day (normally 8-12 hours). TRE have been able to reduce fat mass, pro-inflammatory markers (eg IL-6, TNF-a) and have improved some biomarkers related to cardiovascular risks (eg Insulin, HDL, TG).

The literature offers numerous versions of intermittent fasting, and the role of fasting duration is not yet fully clear. Thus. the aim of the present study is to investigate the effect od different duration of fasting in a TRE protocol on body composition and lipid and inflammatory profile. Moreover, the study intended to explore the effect of 2 month of TRE on long term maintenance of diet habits, body composition, lipid and inflammatory profile.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Diet Fasting, Intermittent

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Effect of fasting duration

study the effect of different daily fasting duration on body composition and blood lipid and inflammatory markers in healthy adults.

Group Type ACTIVE_COMPARATOR

Time Restricted Eating

Intervention Type OTHER

Effect of 16, 14 or 12 hours of daily fasting

Effect of time restricted eating protocol on chronotype

study the effect of 2 month of time restricted eating on the chronotype profile of healthy adults.

Group Type OTHER

Time Restricted Eating

Intervention Type OTHER

Effect of 16, 14 or 12 hours of daily fasting

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Time Restricted Eating

Effect of 16, 14 or 12 hours of daily fasting

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMI between 18-30 kg/m2
* Stable body weight for at least 3 months

Exclusion Criteria

* type 2 Diabetes or pre-diabetes for ADA guidelines
* Significant Chronic disease
* recent and acute inflammatory status
* Recent (within 3 months) treatment with anabolic steroids, systemic corticosteroids or estrogen.
* regular exercise training (≥ 2 sessions/week) or ≥ 10,000 steps/day
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Padova

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Antonio Paoli

Full Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tatiana Moro, Ph.D

Role: PRINCIPAL_INVESTIGATOR

University of Padova

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nutrition and Exercise Lab, DSB, University of Padova

Padua, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tatiana Moro, Ph.D

Role: CONTACT

0498275306

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tatiana Moro, PhD

Role: primary

0498275306

References

Explore related publications, articles, or registry entries linked to this study.

Sampieri A, Paoli A, Spinello G, Santinello E, Moro T. Impact of daily fasting duration on body composition and cardiometabolic risk factors during a time-restricted eating protocol: a randomized controlled trial. J Transl Med. 2024 Nov 29;22(1):1086. doi: 10.1186/s12967-024-05849-6.

Reference Type DERIVED
PMID: 39614235 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FaTE-TRE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.